Filter posts

Coming Down the Pipeline: Patent Cases to Watch in 2017

The Supreme Court returns from recess on February 17, and alongside the likely confirmation of …

IP Sessions at BIO 2016--Come Join us in San Francisco!

That’s right, we’re back at it again! This year’s BIO International Convention will host several innovative …

102 Organizations Urge Congress to Maintain a Strong Patent System and Protect Innovation

A diverse group of more than 100 national and state-based advocacy organizations have united to …

Seventy Nine House Members Express Concern with H.R. 9

House leaders made the decision earlier this month to remove patent reform legislation from the …

FDA Acts on Biosimilars

The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration …

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …

Updated Legal and Regulatory Frameworks Needed for Biosimilars

Biosimilars raise novel and complex questions of science and law that require updated legal and …